Chemical Structure (Emend Iv 01)
Emend
Product Images NDC 0006-3884
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emend (NDC 0006-3884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (Carton 115 mg)
Principal Display Panel (150 mg Vial Carton)
Emend® (fosaprepitant dimeglumine) is a sterile lyophilized powder in a single-dose vial for intravenous use. It is only to be used after reconstitution and dilution and is stable for 24 hours at room temperature. The usual dosage is mentioned in the prescription information. The vial must be refrigerated at 2°C-8°C (36°F-46°F). The drug should not be used with solutions containing divalent cations, including lactated Ringer's solution and Hartmann's solution. Inactive ingredients include edetate disodium, polsorbate 80, anhydrous lactose, sodium hydroxide, and hydrochloric acid for pH adjustment. The manufacturer of Emend® is MerckSharp & Dohme, a subsidiary of Merck & Co., Inc. The active ingredient is formulated in the US and is from France.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
